Christopher P. Prior
Director Ejecutivo en InterAx Biotech AG .
Cargos activos de Christopher P. Prior
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
InterAx Biotech AG
 InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Director Ejecutivo | 24/01/2023 | - |
Historial de carrera de Christopher P. Prior
Antiguos cargos conocidos de Christopher P. Prior.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| 9 METERS BIOPHARMA, INC. | Director/Miembro de la Junta | 01/01/2015 | 19/02/2019 |
| Director Ejecutivo | 01/01/2015 | 19/02/2019 | |
| PHASEBIO PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/04/2008 | 01/09/2014 |
| Director Ejecutivo | 01/04/2008 | 01/09/2014 | |
Innovate Biopharmaceuticals, Inc. /Old/
 Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Director Ejecutivo | - | - |
Principia Pharmaceutical Corp
 Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Fundador | - | - |
| Presidente | - | - | |
| Rhône Poulenc Pharma, Inc. | Director Técnico/Científico/I+D | - | - |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | - | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Christopher P. Prior.
| University of London | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
| Reino Unido | 2 |
| Canadá | 2 |
Operativa
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
| Rhône Poulenc Pharma, Inc. | |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Health Technology |
Innovate Biopharmaceuticals, Inc. /Old/
Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Health Technology |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Christopher P. Prior
- Experiencia
